PITTSBURGH, 29. Januar 2026 /PRNewswire/ — MolecuLight gab heute bekannt, dass sein MolecuLightDX® Wundmessgerät von der US-amerikanischen Food and Drug…
Read More
Collaboration unites Repertoire’s DECODE™ platform to develop T cell targeted immune medicines with Lilly’s commitment to bringing transformative medicines to…
Read More
Market leading Get Well patient engagement solutions will focus on helping drive higher HCAHPS scores, improve operations, and reduce adverse…
Read More
PITTSBURGH, Jan. 29, 2026 /PRNewswire/ — MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S.…
Read More